AlphaGrep UK Ltd’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$578K Buy
1,974
+1,085
+122% +$357K 0.17% 178
2025
Q4
$312K Buy
+889
New +$300K 0.1% 408

Other funds holding ELV

AlphaGrep UK Ltd's ELV Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Elevance Health (ELV) stake by 122% in Q1 2026, buying an estimated $357K and bringing the position to 1,974 shares worth $578K. The position accounts for 0.17% of the portfolio, ranked #178.

AlphaGrep UK Ltd first reported a position in ELV in Q4 2025 and has held it in 2 quarters since. 1,468 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • AlphaGrep UK Ltd held 1,974 shares of Elevance Health worth $578K as of Q1 2026.
  • AlphaGrep UK Ltd bought 1,085 Elevance Health shares in Q1 2026, an estimated $357K.
  • Elevance Health made up 0.17% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #178 holding.
  • AlphaGrep UK Ltd first reported a position in Elevance Health in Q4 2025 and has held it in 2 quarters since.
  • 1,468 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.